Miguel A. Lopez Toledano

Miguel A. Lopez Toledano has a diverse work experience in the field of neuroscience and pharmaceutical project management. Miguel A. started their career as a Graduate Student at Hospital Ramon y Cajal, where they focused on the isolation and characterization of neural stem cells. During this time, they published eight scientific papers in high impact journals.

Miguel A. then continued their research as a Postdoc at Columbia University Medical Center, specializing in the application of neural stem cells to Alzheimer's disease. Miguel A. contributed to four publications in high impact journals and collaborated on research projects with funding of over $1,500,000.

Afterwards, Miguel worked as a Researcher and Assistant Professor at Universidad de Cadiz, where they focused on neurogenesis, histology, imaging, microscopy, and molecular biology. Miguel A. published two papers in high impact journals and collaborated on research projects with funding of over 50,000 euros.

Miguel A. further advanced their career at The Scripps Research Institute Scripps Florida as a Research Associate and later as a Staff Scientist. Here, they continued to contribute to the fields of neurogenesis, RNAi, and AAV gene expression in mouse models of Alzheimer's disease. Miguel A. published four papers in high impact journals and collaborated on research projects with funding totaling more than $3,000,000.

Miguel then joined Florida Atlantic University as a Research Assistant Professor, where they focused on neural stem cells, neurodegenerative disorders, and cancer. Miguel A. published two papers in high impact journals, taught a course on Research in Neuroscience, participated in seminars, and mentored eight undergraduate and graduate students.

Miguel A. later became an Affiliated Assistant Professor at the University of Miami, collaborating on the study of non-coding RNA involvement in BDNF expression and its application in neurodegenerative disorders.

In 2014, Miguel transitioned to industry, joining Sancilio & Company as a Senior Scientist and Project Manager. Miguel A. played a key role in a phase II clinical trial for Sickle Cell Disease and successfully managed multiple preclinical trials.

Following that, they worked at Micelle BioPharma as a Scientific Affairs and Project Management professional. Miguel A. was responsible for scientific affairs, including publication planning, grant writing, and evaluation, as well as clinical and pre-clinical development.

Most recently, Miguel joined Neurelis, Inc. as a Medical Science Liaison and subsequently became the Director of Project Management. In this role, they oversee project management activities and serves as a liaison between the company and the medical community.

Overall, Miguel A. Lopez Toledano has a strong background in neuroscience research, pharmaceutical project management, and scientific publications.

Miguel A. Lopez Toledano has a diverse education history. Miguel A. started their academic journey at Colegio Calderón de la Barca from 1976 to 1984, obtaining a degree in EGB. Miguel A. then attended Instituto Bachillerato Butarque from 1984 to 1988, where they earned a degree in BUP with a focus on Ciencias.

Following this, Miguel enrolled in Universidad Complutense de Madrid from 1988 to 1995, earning a Bachelor's degree in Biology. Miguel A. continued their education at the same university from 1995 to 1996, obtaining a Certificate of Pedagogic Aptitude in Education in Biology and Geology.

Miguel pursued further education at Universidad Complutense de Madrid, where they completed a Ph.D. in Neurosciences from 1997 to 2001.

In 2019, they joined IMQ Iberica Business School and Fundacion UNED to pursue a Master of Business Administration (MBA) focusing on Business, which they completed in 2020.

Furthermore, Miguel has acquired additional certifications to enhance their professional skills. Miguel A. obtained the Project Management Professional (PMP) certification from the Project Management Institute in March 2023. In March 2022, they completed the "Fundamentals of Project Planning and Management" certification from the University of Virginia. Additionally, they obtained the Clinical Research Coordinator (CRC) certification from the CITI Program in June 2021.